Emerging Company and Venture Capital

Helping clients launch their businesses and transform their innovative ideas into successful companies.

Key Contacts

Meet Our Team

WilmerHale Launch

A resource for entrepreneurs and founders of startups in various stages of growth, WilmerHale Launch is your source for answers to the questions that impact you every day. We provide the tools and information you need to build your knowledge and position your startup for success.


  • Represented Accion Systems, a provider of in-space propulsion systems, in its $42 million Series C financing round.
  • Represented Acquco, a platform focused on acquiring third-party sellers on Amazon, in its $160 million Series A financing round.
  • Represented Dedrone, an automated drone security platform, in its $30.5 million later-stage financing round. 
  • Represented DriveWealth, a pioneer in fractional trading and embedded finance, in its $450 million Series D funding round.
  • Represented Embark Veterinary, a provider of dog DNA tests, in its $75 million Series B financing round.
  • Represented Exo Therapeutics, a drug discovery and development company, in its $78 million Series B financing round.
  • Represented Flare Therapeutics, a developer of medicines designed for precision oncology, in its $82 million Series A financing round.
  • Represented GentiBio, a biotherapeutics company developing engineered regulatory T cell therapies, in its $157 million Series A financing round.
  • Represented HawkEye 360, a commercial provider of space-based radio frequency data and analytics, in its $145 million Series D financing round. 
  • Represented Immuta, an AI data management software developer, in a $90 million late stage financing round.
  • Represented Introhive, one of the fastest-growing AI-powered sales and revenue acceleration platforms, in its $100 million Series C financing round.
  • Represented Mahana Therapeutics, a digital therapeutics company in the gastrointestinal treatment space, in its $61 million Series B financing round.
  • Represented Orna Therapeutics, a biotechnology company pioneering engineered circular therapies, in its $221 million Series B financing round.
  • Represented Rectify Therapeutics, a company developing therapies to treat genetic disorders, in its $100 million Series A financing round.
  • Represented Stash, a fintech platform revolutionizing investment and financial literacy across the United States, in several financing rounds including its $125 million Series G funding.
  • Represented Tvardi Therapeutics, a biotechnology company developing medicines for cancers and other diseases, in its $74 million Series B financing round.
  • Represented Workit Health, a digital healthcare company that provides online and in-person care, in its $118 million Series C financing round.
  • Represented Workrise, a workforce management solution for the industrial trades, in a $300 million Series D financing round.
  • Represented investors such as Bessemer Venture Partners, Crosslink Capital, General Catalyst, Khosla Ventures, North Bridge Venture Partners, RA Capital, Samsara BioCapital, Spark Capital, Thrive Capital and Wellington Management, among numerous others, in venture financings.


  • Award Text

    Recognized as a Top Firm in the Nation for Startups & Emerging Companies

    Chambers USA


  • Award Text

    Recommended for Venture Capital and Emerging Companies

    The Legal 500 United States


  • Award Text

    Named a Leading Law Firm for Venture Capital Law

    U.S. News - Best Lawyers®


  • Chambers USA: America’s Leading Lawyers for Business – Again named our corporate practice among the best in 2022, with sources saying that WilmerHale's corporate team is “proactive in its thinking” and are “very strategic thinkers.” The current edition of Chambers USA also ranked WilmerHale in the following related regions and practices: nationwide for Startups & Emerging Companies; California for Venture Capital; Massachusetts for Corporate/M&A, Private Equity: Venture Capital Investment, and Technology; and Washington DC for Corporate/M&A & Private Equity. WilmerHale was also ranked among the top FinTech law firms in the US in its 2021 FinTech guide.
  • The Legal 500 United States – Recognized WilmerHale among top law firms for our work in the area of Venture Capital and Emerging Companies in its 2010–2022 editions.
  • U.S. News - Best Lawyers® – Recognized in the 2010–2023 “Best Law Firms” rankings. In the 2023 rankings, our corporate, mergers and acquisitions, and venture capital law practices were ranked in the first tier nationally and in Boston, and our corporate law practice was also ranked in the first tier in Colorado, New York and Washington DC.  A source describes our venture capital practice as “impeccable and indispensable. They answer the questions, identify the guardrails, and draw on their experience to help us anticipate strategic opportunities. Their superb legal guidance has allowed us to focus on business growth.”
  • Best Lawyers in America – Recognized 129 WilmerHale partners for 2021, naming eight as “Lawyers of the Year.”
  • Corporate Board Member – In 2014, 2016 and 2018, the most recent edition, WilmerHale was named to Top National Corporate Law Firms list, a comprehensive ranking of the top 25 firms in the nation. Results are based on law firm surveys and feedback from thousands of directors and general counsel.
  • Law360 – Named WilmerHale a Technology Practice Group of the Year in 2016-2018 and 2022, an award recognizing the firm’s key role in the significant matters that made headlines and changed the legal landscape, for three consecutive years. 
  • LMG Life Sciences – Named WilmerHale the US Life Cycle Firm of the Year in 2017–2022 and among the shortlist from 2012–2022. LMG has also ranked the firm in its 2012–2022 editions in corporate, licensing and collaboration, M&A, venture capital and several other practice areas, and named 22 WilmerHale lawyers as “life sciences stars.”
  • Super Lawyers – Our corporate lawyers are consistently recognized as “Super Lawyers” and “Rising Stars” in multiple jurisdictions.

Insights & News